Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

HHS vs CODI: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CODI Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 6–4 Matrix Metrics)

CODI Overall Winner 6-Pillar Tally: HHS 2 – 4 CODI Matrix Metrics: HHS 4 – 6 CODI

As of Nov 16, 2026, Compass Diversified (CODI) is the stronger overall head-to-head candidate over Harte Hanks, Inc. (HHS) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, Options & Positioning). HHS carries a Unified Composite Score of 61.8/100 (BUY) at $3.84 (14.3x Forward P/E, -3.2% operating margin), whereas CODI carries 49.6/100 (HOLD) at $11.49 (19.1x Forward P/E, 3.0% operating margin).

  • Composite vs. Pillar Nuance: While HHS currently prints a higher short-term Unified Composite Score (61.8/100 BUY vs. CODI 49.6/100 HOLD), CODI captures the overall institutional head-to-head verdict (6–4 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (3.0% vs. -3.2% operating margin) and revenue trajectory (-10.5% vs. -1.7% YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About HHS vs CODI
HHS US Equity
Harte Hanks, Inc.
Services-Direct Mail Advertising Services
$3.84
-4.24% 1D
Market Cap $30.0M
TTM Revenue $155M
Forward P/E 14.3x
Beta / 30D Vol 0.49β · 46% Vol
Unified Composite Score
61.8 / 100 BUY
Tech 76.0 Fund 61.0 Flow 50.0 Mom 54.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 38
RSI-14: 38.2 · SMA20: $3.95 · SMA50: $4.26
CODI NYSE Head-to-Head Winner
Compass Diversified
Household Furniture
$11.49
-1.3% 1D
Market Cap $858.4M
TTM Revenue $1.74B
Forward P/E 19.1x
Beta / 30D Vol 0.71β · 48% Vol
Unified Composite Score
49.6 / 100 HOLD
Tech 41.0 Fund 49.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 52
RSI-14: 51.7 · SMA20: $11.26 · SMA50: $11.10

6-Pillar Scorecard Institutional Category Breakdown (HHS 2 – 4 CODI)

Columns: Metric · HHS · CODI
1. Valuation Multiples HHS
Forward P/E 14.3x 19.1x
Trailing P/E 14.3x 11.9x
PEG Ratio 1.19x 2.65x
EV / Revenue 0.3x 1.3x
2. Growth & Scale HHS
Revenue Growth (YoY) -1.7% -10.5%
Earnings Growth (YoY) -90.3% -96.3%
TTM Revenue (USD) $155M $1.74B
Market Cap $30.0M $858.4M
3. Profitability & Quality CODI
Gross Margin 16.1% 45.3%
Operating Margin -3.2% 3.0%
Net Profit Margin -3.7% 0.0%
Return on Equity (ROE) -30.4% -1.1%
4. Balance Sheet & Cash Flow CODI
Cash Generation (TTM) -$4.5M $124M
Cash Flow Margin -2.9% 7.1%
Net Cash / Leverage $17M Net Debt (1.10x D/E) $1.43B Net Debt (3.23x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning CODI
Options Structure Phase UNCLASSIFIED CONSOLIDATION
Current IV / %ile N/A (N/A) 57.3% (14th %ile)
Put/Call OI Skew N/A 0.03x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Neutral ACCUMULATION · Neutral
6. R&D & Supply-Chain Moat CODI
OpEx & R&D Intensity 19.3% of Rev ($30M) 42.3% of Rev ($737M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Conglomerates Operator Conglomerates Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: HHS (4) vs CODI (6)
Institutional Metric HHS CODI Criterion Row Edge
Market Capitalization
Scale
$30.0M $858.4M Larger Scale CODI
Trailing P/E Ratio
Valuation
14.3x 11.9x Lower Multiple CODI
Forward P/E Ratio
Valuation
14.3x 19.1x Lower Multiple HHS
Revenue Growth (YoY)
Growth
-1.7% -10.5% Higher Growth HHS
Operating Margin (TTM)
Profitability
-3.2% 3.0% Higher Margin CODI
Net Profit Margin
Profitability
-3.7% 0.0% Higher Margin CODI
Return on Equity (ROE)
Capital Efficiency
-30.4% -1.1% Higher ROE CODI
52-Week Range Position
Momentum
69% ($2–$5) 80% ($5–$13) Stronger Trend CODI
Beta / 30D Volatility
Risk Regime
0.49β · 46% Vol 0.71β · 48% Vol Lower Realized Risk HHS
Unified Institutional Score
Composite Signal
61.8 / 100 (BUY) 49.6 / 100 (HOLD) Higher Composite HHS
Trailing 12M Revenue (USD)
Operating Scale
$155M $1.74B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
16.1% 45.3% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.19x PEG · 0.3x EV/Rev 2.65x PEG · 1.3x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$4.5M ($17M Net Debt (1.10x D/E)) $124M ($1.43B Net Debt (3.23x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CODI +25.26 pp
HHS: -10.49% · CODI: +14.77%
3M Horizon CODI +0.46 pp
HHS: -3.76% · CODI: -3.3%
6M Horizon HHS +44.12 pp
HHS: +36.17% · CODI: -7.95%
1Y Horizon CODI +65.06 pp
HHS: +34.74% · CODI: +99.8%

Financial Trajectory Annualized Quarterly Run-Rate Revenue & Operating Margin Trajectory (USD-Normalized)

Split-Invariant USD Revenue & Operating Margin (%)
Period HHS Revenue CODI Revenue HHS Op. Margin CODI Op. Margin Margin Leader
Q3 '25 $160M $199.8B 2.6% -2.3% HHS
Q4 '25 $160M $198.1B 0.4% 9.8% CODI
Q1 '26 $150M $180.4B -1.6% 4.4% CODI

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
HHS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact HHS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CODI CONSOLIDATION
132d in phase · OBV ACCUMULATION
Current IV 57.3%
IV Percentile 14th %ile
Put/Call OI Skew 0.03x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow ACCUMULATION
Exact CODI Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
HHS Moat Profile Cyclical / Execution-Driven Positioning
Conglomerates Operator
Competes within the Conglomerates value chain with $30.0M market capitalization and -3.2% operating margin.
OpEx & R&D Reinvestment 19.3% of Rev ($30M)
90D Engineering Disclosures 0 Published
CODI Moat Profile Cyclical / Execution-Driven Positioning
Conglomerates Operator
Competes within the Conglomerates value chain with $858.4M market capitalization and 3.0% operating margin.
OpEx & R&D Reinvestment 42.3% of Rev ($737M)
90D Engineering Disclosures 0 Published

Investor FAQ HHS vs CODI Key Questions & Quantitative Answers

As of Nov 16, 2026, Compass Diversified (CODI) is the stronger overall head-to-head candidate over Harte Hanks, Inc. (HHS) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Profitability & Quality, Balance Sheet & Cash Flow, Options & Positioning). HHS carries a Unified Composite Score of 61.8/100 (BUY) at $3.84 (14.3x Forward P/E, -3.2% operating margin), whereas CODI carries 49.6/100 (HOLD) at $11.49 (19.1x Forward P/E, 3.0% operating margin). Composite vs. Pillar Nuance: While HHS currently prints a higher short-term Unified Composite Score (61.8/100 BUY vs. CODI 49.6/100 HOLD), CODI captures the overall institutional head-to-head verdict (6–4 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (3.0% vs. -3.2% operating margin) and revenue trajectory (-10.5% vs. -1.7% YoY).

HHS leads the Growth & Scale pillar: HHS posts -1.7% YoY revenue growth and -90.3% YoY earnings growth on $155M TTM revenue (16.1% gross margin, -3.2% operating margin), compared with CODI at -10.5% YoY revenue growth and -96.3% YoY earnings growth on $1.74B TTM revenue (45.3% gross margin, 3.0% operating margin). Across the 3-period historical trajectory (Q3 '25 to Q1 '26), HHS cumulative revenue shifted -6.2% while CODI shifted -9.7%. In operating R&D and SG&A reinvestment, HHS deploys 19.3% of Rev ($30M) (0 90-day corporate R&D disclosures) versus 42.3% of Rev ($737M) (0 disclosures) for CODI.

HHS screens cheaper on headline valuation multiples. HHS trades at 14.3x Forward P/E, 14.3x Trailing P/E, 1.19x PEG, and 0.3x EV/Revenue (-2.9% FCF margin), whereas CODI trades at 19.1x Forward P/E, 11.9x Trailing P/E, 2.65x PEG, and 1.3x EV/Revenue (7.1% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against HHS (-30.4% ROE) versus CODI (-1.1% ROE) capital efficiency.

In options market volatility and institutional positioning, HHS carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.49β · 46% Vol realized risk). By comparison, CODI carries 57.3% implied volatility (14th %ile, Compressed (<25th %ile)), a 0.03x (Call-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (0.71β · 48% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.